An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)
Clinical trial NCT01513941 · COMPLETED
Trial details
- NCT number
- NCT01513941
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-03-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.